PLANNED MAINTENANCE

There will be scheduled maintenance work beginning on Saturday 15th June 2019 at 8:30 am through to Sunday 16th June 2019 at 11:30 pm (BST).

During this time our website may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.

Data source details

*
None
Kerry Fowler
None

From bench chemistry to research management, I have twenty-eight years of experience in the pharmaceutical industry.

As the first medicinal chemist at ICOS I had the rare opportunity to build a small but top notch medicinal chemistry group.  Along with our biology collegues, we placed eight small molecules into development.  Three of these remain in clinical trials: IC-776, IC-83/LY2603618, and CAL-101Each of these drugs originated in-house as high-throughput screening hits.

Our group worked with a wide network of collaborators and contractors who contributed to our SAR programs: Abbott, Albany Molecular, Array Biopharma, Biogen-Idec, CombiChem, Coromed, Gateway Chemical (now IQSynthesis) Glaxo-Wellcome. 

In 2007 I co-founded Afya World Medicines, a non-profit pharmaceutical compa


None

KWF Consulting  

 

 

 

   

 

 

 

 

 

Personal Collections



 

 

 

Yes

No

No



Advertisement